The Latest Breaking News from Cardiomyopathy

The family of a Doune teenager who tragically died of a rare heart condition have met with Stirling’s MSP. Evelyn Tweed MSP met with Morag and Gilbert Ferrier to discuss the debate on cardiomyopathy and hopes for the future. Earlier this year, Ms T

The family of a Doune teenager who tragically died of a rare heart condition have been praised at Scottish Parliament for their awareness raising and fundraising efforts. Callum Ferrier, described as fit and “sports-mad”, was aged just 16 when his d

CHICAGO — Te’Jaan Ali was playing basketball in a school gym on the South Side of Chicago when he started feeling hot. The heat in the gym — which didn’t have air conditioning — was likely just as bad as the sweltering temperatures outside, which reached 90 degrees on July…

The true story of a male nurse who murdered up to hundreds of patients in US hospitals by secretly administering drug overdoses is brought to the screen by an all-star team of filmmakers in "The Good Nurse". Based on a book of the same name, "The Good Nurse" centers around…

Bristol Myers Squibb (NYSE:BMY) and 2seventy bio (NASDAQ:TSVT) announced positive topline results from KarMMa-3, a Phase 3 study evaluating Abecma (idecabtagene vicleucel) compared to standard combination regimens in adults with multiple myeloma that is relapsed and refractory. Bristol Myers shares traded in a range of $73.95 to $75.32 on a day volume…

Alnylam stock cooled Friday as one expert argued the company will have to run a second study of its cardiomyopathy drug to gain traction.

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ:MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns. MediWound shares traded in a range of $1.6 to $1.76 on a day…

Alnylam stock hit a record high Wednesday after the company reported a "clean hit" for its Pfizer rival cardiomyopathy drug.

In 2018, the FDA began investigating whether the increasing popularity of grain-free dog foods had led to a sudden rise in a potentially fatal heart disease in dogs

Dying of a broken heart was just a figure of speech until 2002 when Dr Hikaru Sato and colleagues at Hiroshima City Hospital described it in a study. Sato named the condition takotsubo cardiomyopathy. It was quickly dubbed “broken heart syndrome”.

Researchers at the University of Aberdeen are examining takotsubo cardiomyopathy.